CVAC Chart
- 52-Week Range: $14.70 - $125.00
- Market Capitalization: $3.37B
- Short Percentage: 0%
- Target Price: $29.96
- Shares Outstanding: 187.12M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
CVAC released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- CureVac's (CVAC) CEO Franz-Werner Haas on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 19th
- Vaccine Stocks: Why MRNA, VXRT, CVAC and NVAX Stocks Need a Band-Aid TodayInvestorPlace | October 1st
- Vaccine Stocks: The Latest News Moving BNTX, CVAC, NVAX Stocks TodayInvestorPlace | August 16th
- How Pfizer and Moderna Could Profit Big-Time From AstraZeneca's and CureVac's ChallengesThe Motley Fool | June 23rd
- What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.InvestorPlace | June 17th
Company Info
Website: https://www.curevac.com
Address: Friedrich-Miescher-Strasse 15, Tübingen, Germany, 72076
Sector: Healthcare
Industry: Biotechnology
Full time employees: 764
Address: Friedrich-Miescher-Strasse 15, Tübingen, Germany, 72076
Sector: Healthcare
Industry: Biotechnology
Full time employees: 764
$CVAC I love this stonk!
$CVAC where’s the WSB guys at? Still sleeping?
$CVAC the best advice has been no stop losses. Would have cost a fortune!!!
$CVAC Bullish!
$CVAC Tomorrow should be a fairly good day.